Top Highlights
-
AI scanned nearly 150,000 Reddit posts to study reports from people claiming to use unapproved retatrutide.
-
The surprise: increased appetite was the most commonly reported classifiable symptom—unlike clinical trials, where digestive issues such as nausea were most common.
-
These reports don’t prove retatrutide caused the symptoms. Users’ accounts can’t be verified, and gray-market products may contain different ingredients or doses.
-
Researchers see AI as an early-warning tool, not a verdict: its online signals need to be checked against independent studies and other data.
AI Spots an Appetite Paradox
Retatrutide is an experimental weight-loss drug that has not received FDA approval. Still, some people say they buy unapproved versions online. Those products are not intended for human use, and their ingredients and doses may vary.
Researchers used AI to review nearly 150,000 Reddit posts and comments. About 14,000 users claimed they had tried an unapproved version. Among people whose symptoms could be classified, increased appetite appeared most often. That stands out: The drug aims to reduce hunger, while clinical trials have mainly reported digestive problems.
Online Reports Offer Clues, Not Proof
The finding does not show that retatrutide causes increased appetite. Researchers cannot confirm what people took, how much they used or whether other substances played a role. Reddit users also differ from people in clinical trials.
Retatrutide targets three hormone receptors involved in appetite and other body functions. That differs from some existing weight-loss drugs. So, its effects may differ, too. But researchers need further studies before they can draw conclusions.
AI Can Help Guide More Research
Drug safety systems rely on clinical trials and reports from health professionals and patients. However, people using unapproved products may not appear in those records. AI can scan large online discussions and flag patterns that researchers might otherwise miss.
That makes social media a potential early-warning tool, not a substitute for medical evidence. Researchers can test online signals against other data. Meanwhile, people considering unapproved drugs face uncertainty about both the product and its risks. Retatrutide remains under study, and its safety and effectiveness still require careful evaluation.
Continue Your Tech Journey
Stay informed on the revolutionary breakthroughs in Quantum Computing research.
Explore past and present digital transformations on the Internet Archive.
AITechV1
